News

InvitroCue Commences Pancreatic Toxicity Assay Development 11 July 2016 – InvitroCue (ASX:IVQ), a leader in advanced bio-analytics, has progressed its technology in modeling multi-organ toxicity

Nature Scientific Reports Article Touts Versatility, Promise of 3D Human Liver Microtissues for Drug Development Schlieren, Switzerland, June 16, 2016 – Liver spheroids display longer

InSphero Launches Multi-donor Human Liver Microtissues for Prediction of Drug-induced Liver Injury Schlieren, Switzerland, March 16, 2016 – 3D human liver microtissues comprised of pooled

InSphero Contributes 3D Microtissue-based Assay Chapter to NCATS/NIH Assay Guidance Manual Schlieren, Switzerland, February 10, 2016 – Latest update of industry manual for development of

InSphero Inc. Streamlines 3D Microtissue Business Operations in the US Schlieren, Switzerland, February 01, 2016 – US subsidiary of Swiss-based InSphero AG initiates direct product

InSphero and NCATS to Present Collaborative 3D Cancer Screening Study at SLAS2016 Annual Meeting Schlieren, Switzerland, January 25, 2016 – Study describes high-throughput compatible screening

InSphero Adds Head of Sales, Expands Global Sales Team Schlieren, Switzerland, January 21, 2016 – Beate Schnell, Ph.D. joins senior team at global leader in

InSphero's CEO Jan Lichtenberg wins Entrepreneur of the Year™ 2015 Schlieren, Switzerland, Oct 23, 2015 – Dr. Jan Lichtenberg, CEO and co-founder of InSphero AG

InSphero Receives € 750K Funding from EU-ToxRisk Consortium Schlieren, Switzerland, Oct 21, 2015 – In a large (€ 30 MM) H2020-supported collaborative project, leading 3D

InSphero Adds Chief Financial Officer to Senior Management Team Schlieren, Switzerland, Oct 15, 2015 – Oliver Krähenbühl brings 25 years of finance experience in the

InSphero Launches 14 Day Hepatotoxicity Testing Service Schlieren, Switzerland, Oct 13, 2015 – Monthly contract screening service simplifies long-term, repeat-dose testing of drugs in 3D

InSphero Granted Hanging Drop Patent in United States Schlieren, Switzerland, September 29, 2015 – Patent establishes protection of InSphero GravityPLUSTM technology in all major global markets, key

InSphero Expands Global Availability of its Patented 3D Cell Culture Platforms Schlieren, Switzerland, August 5, 2015 – PerkinElmer was named as exclusive distributor of InSphero

InSphero AG Secures CHF 20 Million Series C Financing Schlieren, Switzerland, July 8, 2015 – Leading 3D cell culture company gains new long-term investor to

InSphero Launches Enhanced Ultra-low Attachment Plate for Scaffold-free 3D Cell Culture Schlieren, Switzerland, May 7, 2015 – GravityTRAP™ ULA Plate design simplifies medium exchange and